We are live on ! Find out more
AP

AHL Partners Portfolio holdings

AUM $6.41B
1-Year Est. Return 23.14%
This Fund
S&P 500
This Quarter Est. Return
+1.39%
1 Year Est. Return
+23.14%
3 Year Est. Return
+67.81%
5 Year Est. Return
10 Year Est. Return
AUM
$2.51B
AUM Growth
+$5.83M
Cap. Flow
+$9.27M
Cap. Flow %
0.37%
Top 10 Hldgs %
3.8%
Holding
938
New
159
Increased
383
Reduced
279
Closed
117
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UMBF icon
151
UMB Financial
UMBF
$11.1B
$5.3M 0.21%
+93,028
New +$5M
ISEE
152
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$5.28M 0.21%
101,406
-11,582
-10% -$576K
TOL icon
153
Toll Brothers
TOL
$14.3B
$5.28M 0.21%
138,126
+54,830
+66% +$2.05M
MTD icon
154
Mettler-Toledo International
MTD
$26.4B
$5.26M 0.21%
15,419
-1,621
-10% -$534K
CNMD icon
155
CONMED
CNMD
$1.31B
$5.26M 0.21%
+90,302
New +$4.87M
PEP icon
156
PepsiCo
PEP
$186B
$5.25M 0.21%
56,206
+17,477
+45% +$1.67M
AMGN icon
157
Amgen
AMGN
$197B
$5.24M 0.21%
34,114
-278
-0.8% -$44.5K
ISRG icon
158
Intuitive Surgical
ISRG
$124B
$5.22M 0.21%
97,020
+31,338
+48% +$1.75M
BIO icon
159
Bio-Rad Laboratories Class A
BIO
$8.11B
$5.21M 0.21%
34,625
-5,952
-15% -$852K
IQV icon
160
IQVIA
IQV
$34.5B
$5.21M 0.21%
71,782
-10,302
-13% -$706K
EWBC icon
161
East-West Bancorp
EWBC
$18.4B
$5.21M 0.21%
+116,262
New +$4.98M
TMO icon
162
Thermo Fisher Scientific
TMO
$198B
$5.18M 0.21%
39,937
+12,975
+48% +$1.69M
CPB icon
163
Campbell Soup
CPB
$6.6B
$5.16M 0.21%
108,268
+32,481
+43% +$1.52M
KDP icon
164
Keurig Dr Pepper
KDP
$41.9B
$5.16M 0.21%
70,742
+24,073
+52% +$1.84M
MYGN icon
165
Myriad Genetics
MYGN
$584M
$5.15M 0.21%
151,562
-1,384
-0.9% -$47.1K
WAT icon
166
Waters Corp
WAT
$36.3B
$5.15M 0.21%
40,127
-4,124
-9% -$535K
TARO
167
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$5.15M 0.21%
35,837
-3,344
-9% -$477K
GIS icon
168
General Mills
GIS
$20.2B
$5.14M 0.2%
92,168
+26,779
+41% +$1.5M
UVV icon
169
Universal Corp
UVV
$1.32B
$5.14M 0.2%
+89,613
New +$4.53M
QGENF
170
DELISTED
QIAGEN NV
QGENF
$5.13M 0.2%
206,976
-5,581
-3% -$138K
UTHR icon
171
United Therapeutics
UTHR
$22.8B
$5.13M 0.2%
29,491
-1,282
-4% -$231K
BMY icon
172
Bristol-Myers Squibb
BMY
$124B
$5.06M 0.2%
76,052
-6,777
-8% -$447K
VWR
173
DELISTED
VWR Corporation
VWR
$5.05M 0.2%
188,870
-13,910
-7% -$371K
SF
174
Stifel
SF
$11.9B
$5.04M 0.2%
+196,216
New +$4.84M
KO icon
175
Coca-Cola
KO
$351B
$5.03M 0.2%
128,181
+52,173
+69% +$2.12M

Similar funds

AHL Partners's Q2 2015 Portfolio in Review

As of Q2 2015, AHL Partners held 938 positions worth $2.51B, up 0.23% from $2.5B the previous quarter. Its ten largest holdings account for 3.8% of the portfolio.

AHL Partners's Q2 2015 filing shows 159 new, 383 increased, 279 reduced and 117 closed positions. Its largest new stake was Bank of Montreal: 131,962 shares worth $7.82M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $31.9M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • AHL Partners's largest Q2 2015 buy was Bank of Montreal: 131,962 shares worth $7.82M.
  • AHL Partners added most to CIT Group Inc. in Q2 2015, an estimated $7.88M increase.
  • AHL Partners's biggest Q2 2015 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $18.3M.
  • AHL Partners fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2015, selling an estimated $31.9M.
  • AHL Partners's ten largest holdings make up 3.8% of its $2.51B portfolio in Q2 2015.
  • AHL Partners opened 159 new positions and closed 117 in Q2 2015.
  • AHL Partners's portfolio value rose 0.23% quarter-over-quarter to $2.51B.

Based on AHL Partners's 13F filing for Q2 2015, filed 14 Aug 2015.